{"id":164713,"date":"2024-10-07T08:24:41","date_gmt":"2024-10-07T12:24:41","guid":{"rendered":"https:\/\/44.250.171.167\/?p=164713"},"modified":"2024-10-07T08:24:42","modified_gmt":"2024-10-07T12:24:42","slug":"gufic-biosciences-ltd-q1fy25-4-rise-in-revenue","status":"publish","type":"post","link":"https:\/\/alphastreet.com\/india\/gufic-biosciences-ltd-q1fy25-4-rise-in-revenue\/","title":{"rendered":"Gufic BioSciences Ltd Q1FY25; 4% rise in Revenue"},"content":{"rendered":"\n<p>Gufic Biosciences Limited is engaged in the manufacture of pharmaceuticals, medicinal chemicals and botanical products.<\/p>\n\n\n\n<p style=\"font-size:24px\"><strong>Financial Results:<\/strong><\/p>\n\n\n\n<p>Gufic BioSciences Ltd reported Revenues for Q1FY25 of \u20b9203.00 Crores up from \u20b9195.00 Crore year on year, a rise of 4.1%.<\/p>\n\n\n\n<p>Total Expenses for Q1FY25 of \u20b9176.00 Crores up from \u20b9168.00 Crores year on year, a rise of 4.76%.<\/p>\n\n\n\n<p>Consolidated Net Profit of \u20b921.00 Crores from \u20b921.00 Crores in the same quarter of the previous year.<\/p>\n\n\n\n<p>The Earnings per Share is \u20b92.08, down 2.35% from \u20b92.13 in the same quarter of the previous year.<\/p>\n\n\n\n<figure class=\"wp-block-image size-large\"><img loading=\"lazy\" decoding=\"async\" width=\"839\" height=\"1024\" src=\"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2024\/10\/image-33-839x1024.png\" alt=\"\" class=\"wp-image-164714\" srcset=\"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2024\/10\/image-33-839x1024.png 839w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2024\/10\/image-33-246x300.png 246w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2024\/10\/image-33-768x937.png 768w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2024\/10\/image-33-1259x1536.png 1259w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2024\/10\/image-33.png 1489w\" sizes=\"auto, (max-width: 839px) 100vw, 839px\" \/><\/figure>\n\n\n\n<p>*It is important to note that the way the results have been accounted for are slightly different than the ones the companies may choose to publish.<\/p>\n\n\n\n<p>*The presented data is automatically generated. It may occasionally generate incorrect information.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Gufic Biosciences Limited is engaged in the manufacture of pharmaceuticals, medicinal chemicals and botanical products. Financial Results: Gufic BioSciences Ltd reported Revenues for Q1FY25 of \u20b9203.00 Crores up from \u20b9195.00 Crore year on year, a rise of 4.1%. Total Expenses for Q1FY25 of \u20b9176.00 Crores up from \u20b9168.00 Crores year on year, a rise of [&hellip;]<\/p>\n","protected":false},"author":1932,"featured_media":164714,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[105,392],"tags":[2132],"class_list":["post-164713","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-infographics","category-earnings","tag-manufacturing"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2024\/10\/image-33.png","jetpack_likes_enabled":false,"jetpack-related-posts":[{"id":153038,"url":"https:\/\/alphastreet.com\/india\/gufic-biosciences-ltd-q1fy24-18-rise-in-revenue\/","url_meta":{"origin":164713,"position":0},"title":"Gufic BioSciences Ltd Q1FY24; 18% rise in Revenue","author":"Hardik Bhandare","date":"August 11, 2023","format":false,"excerpt":"Gufic Biosciences Limited is engaged in the manufacture of pharmaceuticals, medicinal chemicals and botanical products. Financial Results: Gufic BioSciences Ltd reported Revenues for Q1FY24 of \u20b9195.00 Crores up from \u20b9165.00 Crore year on year, a rise of 18.18%. Total Expenses for Q1FY24 of \u20b9168.00 Crores up from \u20b9137.00 Crores year\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-787.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-787.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-787.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-787.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-787.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-787.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":156834,"url":"https:\/\/alphastreet.com\/india\/gufic-biosciences-ltd-q2fy24-15-rise-in-profits\/","url_meta":{"origin":164713,"position":1},"title":"Gufic BioSciences Ltd Q2FY24; 15% rise in Profits","author":"Hardik Bhandare","date":"November 29, 2023","format":false,"excerpt":"Gufic Biosciences Limited is engaged in the manufacture of pharmaceuticals, medicinal chemicals and botanical products. Financial Results: Gufic BioSciences Ltd reported Revenues for Q2FY24 of \u20b9215.00 Crores up from \u20b9175.00 Crore year on year, a rise of 22.86%. Total Expenses for Q2FY24 of \u20b9184.00 Crores up from \u20b9149.00 Crores year\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/11\/image-375.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/11\/image-375.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/11\/image-375.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/11\/image-375.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/11\/image-375.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/11\/image-375.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":162626,"url":"https:\/\/alphastreet.com\/india\/gufic-biosciences-ltd-q4fy24-11-rise-in-profits\/","url_meta":{"origin":164713,"position":2},"title":"Gufic BioSciences Ltd Q4FY24; 11% rise in Profits","author":"Divyansh_Kasana","date":"July 1, 2024","format":false,"excerpt":"Gufic Biosciences Limited is engaged in the manufacture of pharmaceuticals, medicinal chemicals and botanical products. Financial Results: Gufic BioSciences Ltd reported Revenues for Q4FY24 of \u20b9195.00 Crores up from \u20b9173.00 Crore year on year, a rise of 12.72%. Total Expenses for Q4FY24 of \u20b9169.00 Crores up from \u20b9150.00 Crores year\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/07\/image-1.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/07\/image-1.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/07\/image-1.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/07\/image-1.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/07\/image-1.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/07\/image-1.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":156403,"url":"https:\/\/alphastreet.com\/india\/gufic-biosciences-limited-q2-fy24-earnings-conference-call-insights\/","url_meta":{"origin":164713,"position":3},"title":"Gufic Biosciences Limited Q2 FY24 Earnings Conference Call Insights","author":"Praveen","date":"November 17, 2023","format":false,"excerpt":"Key highlights from Gufic Biosciences Limited (GUFICBIO) Q2 FY24 Earnings Concall New Product Launches and Approvals Launched new products like Dalbavancin and SeraSeal across divisions. The company received regulatory approvals for products in markets like Sri Lanka, Chile, Malaysia, Australia and Brazil. Expecting approvals for Immunocin-Alpha and dual-chamber bags with\u2026","rel":"","context":"In &quot;Concall Highlights&quot;","block_context":{"text":"Concall Highlights","link":"https:\/\/alphastreet.com\/india\/category\/earnings-call-highlights\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/10\/CC_Image_1.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/10\/CC_Image_1.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/10\/CC_Image_1.jpg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/10\/CC_Image_1.jpg?resize=700%2C400&ssl=1 2x"},"classes":[]},{"id":154805,"url":"https:\/\/alphastreet.com\/india\/gufic-biosciences-advancements-strategic-developments-in-pharmaceuticals\/","url_meta":{"origin":164713,"position":4},"title":"Gufic BioSciences: Advancements &#038; Strategic Developments in Pharmaceuticals","author":"Hardik Bhandare","date":"October 11, 2023","format":false,"excerpt":"\u201cWe are also happy to announce that Gufic has secured DCGI approval for the manufacturing and marketing of Dalbavancin and we are the first Company to receive such approval in India. Trial for sepsis involving Immunocin Alpha have completed successfully and we anticipate the DGCI approval by Q3 of this\u2026","rel":"","context":"In &quot;Research Summary&quot;","block_context":{"text":"Research Summary","link":"https:\/\/alphastreet.com\/india\/category\/research-summary\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/10\/b4654e61-a1d5-4b7f-8d9b-2f1140b01114-3.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/10\/b4654e61-a1d5-4b7f-8d9b-2f1140b01114-3.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/10\/b4654e61-a1d5-4b7f-8d9b-2f1140b01114-3.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/10\/b4654e61-a1d5-4b7f-8d9b-2f1140b01114-3.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/10\/b4654e61-a1d5-4b7f-8d9b-2f1140b01114-3.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/10\/b4654e61-a1d5-4b7f-8d9b-2f1140b01114-3.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":164326,"url":"https:\/\/alphastreet.com\/india\/refex-industries-ltd-q1fy25-38-rise-in-profits\/","url_meta":{"origin":164713,"position":5},"title":"Refex Industries Ltd Q1FY25; 38% rise in Profits","author":"Divyansh_Kasana","date":"September 16, 2024","format":false,"excerpt":"Refex Industries Limited specializes in trading eco-friendly refrigerant gases and providing comprehensive solutions for responsible coal procurement and ash disposal. Financial Results: Refex Industries Ltd reported Revenues for Q1FY25 of \u20b9595.00 Crores up from \u20b9382.00 Crore year on year, a rise of 55.76%. Total Expenses for Q1FY25 of \u20b9559.00 Crores\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/09\/image-44.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/09\/image-44.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/09\/image-44.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/09\/image-44.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/09\/image-44.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/09\/image-44.png?resize=1400%2C800&ssl=1 4x"},"classes":[]}],"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/164713","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/users\/1932"}],"replies":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/comments?post=164713"}],"version-history":[{"count":0,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/164713\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/media\/164714"}],"wp:attachment":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/media?parent=164713"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/categories?post=164713"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/tags?post=164713"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}